Healthcare provider profile · identity verified

Claudet C Smith, MD

Internal Medicine · BEECH GROVE, IN · NPI 1124012729

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	584	148
Levothyroxine Sodium	Levothyroxine Sodium	396	99
Omeprazole	Omeprazole	336	88
Amlodipine Besylate	Amlodipine Besylate	331	97
Gabapentin	Gabapentin	301	84
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	262	32
Lisinopril	Lisinopril	259	69
Albuterol Sulfate Hfa	Albuterol Sulfate	207	74
Simvastatin	Simvastatin	192	45
Metformin Hcl	Metformin Hcl	181	39
Alprazolam	Alprazolam	180	33
Alendronate Sodium	Alendronate Sodium	163	42
Fluoxetine Hcl	Fluoxetine Hcl	152	41
Losartan Potassium	Losartan Potassium	147	49
Pantoprazole Sodium	Pantoprazole Sodium	145	37
Hydrochlorothiazide	Hydrochlorothiazide	139	42
Metoprolol Succinate	Metoprolol Succinate	133	39
Trazodone Hcl	Trazodone Hcl	130	36
Sertraline Hcl	Sertraline Hcl	121	36
Rosuvastatin Calcium	Rosuvastatin Calcium	120	35
Metformin Hcl Er	Metformin Hcl	110	25
Glimepiride	Glimepiride	109	22
Duloxetine Hcl	Duloxetine Hcl	108	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	103	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	99	11
Potassium Chloride	Potassium Chloride	96	30
Ozempic	Semaglutide	94	19
Metoprolol Tartrate	Metoprolol Tartrate	93	21
Allopurinol	Allopurinol	82	23
Atenolol	Atenolol	79	15
Fluticasone Propionate	Fluticasone Propionate	79	31
Pregabalin	Pregabalin	77	15
Montelukast Sodium	Montelukast Sodium	72	18
Oxybutynin Chloride Er	Oxybutynin Chloride	72	22
Escitalopram Oxalate	Escitalopram Oxalate	71	24
Lorazepam	Lorazepam	71	14
Famotidine	Famotidine	67	19
Pravastatin Sodium	Pravastatin Sodium	67	17
Furosemide	Furosemide	66	21
Citalopram Hbr	Citalopram Hydrobromide	63	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	17
Clonazepam	Clonazepam	56	suppressed
Buspirone Hcl	Buspirone Hcl	55	16
Paroxetine Hcl	Paroxetine Hcl	55	15
Venlafaxine Hcl Er	Venlafaxine Hcl	52	16
Celecoxib	Celecoxib	51	16
Meloxicam	Meloxicam	51	17
Bupropion Xl	Bupropion Hcl	49	15
Tamsulosin Hcl	Tamsulosin Hcl	47	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	15
Mounjaro	Tirzepatide	46	suppressed
Breo Ellipta	Fluticasone/Vilanterol	45	12
Januvia	Sitagliptin Phosphate	44	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	12
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	43	11
Ondansetron Odt	Ondansetron	42	12
Synthroid	Levothyroxine Sodium	42	suppressed
Carvedilol	Carvedilol	41	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	17
Ibuprofen	Ibuprofen	39	11
Ezetimibe	Ezetimibe	37	suppressed
Diazepam	Diazepam	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	suppressed
Glipizide Er	Glipizide	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	17
Doxycycline Hyclate	Doxycycline Hyclate	31	29
Mirtazapine	Mirtazapine	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	suppressed
Temazepam	Temazepam	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	17
Aripiprazole	Aripiprazole	28	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Cephalexin	Cephalexin	26	22
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Baclofen	Baclofen	25	11
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	13
Primidone	Primidone	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Klor-Con M20	Potassium Chloride	24	suppressed
Naproxen	Naproxen	24	11
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Estradiol	Estradiol	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	20
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Linzess	Linaclotide	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Eliquis	Apixaban	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	16	suppressed
Nystatin	Nystatin	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Prednisone	Prednisone	15	14
Valacyclovir	Valacyclovir Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan	Valsartan	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error